跳至主要内容
临床试验/ISRCTN85757829
ISRCTN85757829已完成未知

A multi-centre, feasibility, cluster randomised controlled trial comparing restrictive versus liberal blood transfusion strategies in adult patients admitted with acute upper gastrointestinal bleeding.

HS Blood and Transplant Research & Development (UK)0 个研究点目标入组 849 人开始时间: 2012年7月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
849

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • •1. Adults aged = 18 years presenting with AUGIB, defined by haematemesis or melaena.
  • •2. >20 admissions with AUGIB per month
  • •3. >400 hospital beds
  • •4. Availability of 24 hours endoscopy and on-site access to intensive care and surgical support
  • •5. Institutional agreement to transfuse all eligible new admissions with AUGIB in accordance with the randomised transfusion policy
  • •6. Male & female participants
  • •7. Lower Age Limit 18 years

排除标准

  • •1. Patients for whom the responsible clinician considers there is a need for immediate RBC transfusion prior to obtaining or regardless of the initial Haemoglobin (Hb) result due to severity of bleeding (these patients should be managed according to the hospital's massive transfusion protocol or clinician discretion)
  • •2. Existing hospital inpatients who develop an AUGIB

研究者

发起方
HS Blood and Transplant Research & Development (UK)

相似试验

Transfusion in Gastrointestinal Bleeding (TRIGGER) | 临床试验